Danaher Corp. (DHR)
230.50
+0.75
(+0.33%)
USD |
NYSE |
Oct 23, 16:00
230.65
+0.15
(+0.07%)
Pre-Market: 20:00
Danaher Net Income (Quarterly) : 1.207B for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.207B |
| June 30, 2026 | 870.00M |
| March 31, 2026 | 1.029B |
| December 31, 2025 | 1.183B |
| September 30, 2025 | 908.00M |
| June 30, 2025 | 555.00M |
| March 31, 2025 | 954.00M |
| December 31, 2024 | 1.086B |
| September 30, 2024 | 818.00M |
| June 30, 2024 | 907.00M |
| March 31, 2024 | 1.088B |
| December 31, 2023 | 1.121B |
| September 30, 2023 | 940.00M |
| June 30, 2023 | 1.106B |
| March 31, 2023 | 1.24B |
| December 31, 2022 | 2.012B |
| September 30, 2022 | 1.572B |
| June 30, 2022 | 1.68B |
| March 31, 2022 | 1.725B |
| December 31, 2021 | 1.788B |
| September 30, 2021 | 1.158B |
| June 30, 2021 | 1.699B |
| March 31, 2021 | 1.702B |
| December 31, 2020 | 1.241B |
| September 30, 2020 | 883.50M |
| Date | Value |
|---|---|
| June 30, 2020 | 927.30M |
| March 31, 2020 | 595.10M |
| December 31, 2019 | 792.90M |
| September 30, 2019 | 630.70M |
| June 30, 2019 | 676.40M |
| March 31, 2019 | 332.30M |
| December 31, 2018 | 683.80M |
| September 30, 2018 | 663.70M |
| June 30, 2018 | 673.80M |
| March 31, 2018 | 566.60M |
| December 31, 2017 | 856.60M |
| September 30, 2017 | 572.10M |
| June 30, 2017 | 557.30M |
| March 31, 2017 | 483.80M |
| December 31, 2016 | 747.00M |
| September 30, 2016 | 402.60M |
| June 30, 2016 | 418.00M |
| March 31, 2016 | 585.80M |
| December 31, 2015 | 735.20M |
| September 30, 2015 | 590.00M |
| June 30, 2015 | 695.60M |
| March 31, 2015 | 569.80M |
| December 31, 2014 | 661.70M |
| September 30, 2014 | 680.60M |
| June 30, 2014 | 676.40M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.739B |
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Revvity, Inc. | 53.48M |
| Illumina, Inc. | 207.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.554B |
| Total Expenses (Quarterly) | 5.347B |
| EPS Diluted (Quarterly) | 1.747 |
| Enterprise Value | 184.25B |
| Gross Profit Margin (Quarterly) | 59.34% |
| Profit Margin (Quarterly) | 18.42% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 3.28% |
| Normalized Earnings Yield | 2.733 |